Wegovy® (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH…

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
Fierce Biotech

FDA qualifies 1st AI drug development tool for reading MASH images

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...
Rolling Out

How to protect your liver from the MASH threat danger

A silent health crisis may be developing inside your body without any obvious warning signs. Metabolic dysfunction-associated steatohepatitis (MASH) represents a serious form of fatty liver disease ...
Healio

MASH therapies still needed despite boom in GLP-1 use in liver disease

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. GLP-1 receptor agonist use in diabetes and obesity has ...
MedPage Today

Fibrosis Immune Profiles Appear to Drive Liver Cancer Trajectories in MASH

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new ...
The Hill

Ozempic, Wegovy could reverse severe liver disease, study suggests

International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...
pharmaphorum

FDA backs first AI tool for use in trials, targeting MASH

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...

PathAI's AIM-MASH AI Assist(1) Becomes First AI-Powered Tool to Receive FDA Qualification for MASH Clinical Trials

PathAI, a global leader in AI-powered pathology, today announced that the U.S. Food and Drug Administration (FDA) has qualified AIM-MASH AI Assist through the Drug Development Tool (DDT) Biomarker ...
EurekAlert!

UAB researchers cure liver disease MASH by a one-time gene therapy

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...
Hosted on MSN

Understanding MASH, the Rare Liver Disease Dan Marino Has Been Diagnosed With

Former Miami Dolphins quarterback Dan Marino is opening up about his health in the hope that more people will stay on top of their routine exams. The 64-year-old says that one of those annual visits ...
Rolling Out

Why doctors abandoned this embarrassing liver disease name

Imagine sitting in a doctor’s office and being told you have “non-alcoholic” liver disease. Before the doctor even finishes explaining what that means, your brain is already doing gymnastics trying to ...
The American Journal of Managed Care

Higher Spleen-to-Liver Stiffness Ratio in MASH May Signal Portal Hypertension

MASH patients exhibit a higher spleen-to-liver stiffness ratio than ALD patients, indicating a presinusoidal component in portal hypertension. The study found that MASH patients have larger spleen ...